Immatics Implements Genedata Biologics® into Proprietary T-Cell Receptor Discovery and Engineering XCEPTOR® Platform

BASEL, Switzerland (PRWEB) November 12, 2019 Genedata, the leading provider of enterprise software solutions for biopharmaceutical R&D, today announced that Immatics Biotechnologies , a clinical-stage biopharmaceutical company developing T-cell receptor (TCR)-based cancer immunotherapies…

Source link

Related posts

Put on Your Sunscreen: The Birth of Arabidopsis Abiotic Stress Genetics


Inadvertent Paralog Inclusion Drives Artifactual Topologies and Timetree Estimates in Phylogenomics


Maternal food supplementation and perceived predation risk modify egg composition and eggshell traits but not offspring condition [RESEARCH ARTICLE]


This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy


COVID-19 (Coronavirus) is a new illness that is having a major effect on all businesses globally LIVE COVID-19 STATISTICS FOR World